Cover Image

Off-label use in germany: a current appraisal of gynaecologic university departments

The off-label use, referring to the applicability of pharmaceutical drugs beyond the submitted and from the Federal Institute for Drugs and Medical Devices (BfArM, Bundesamt für Arzneimittel und Medizinprodukte) certified and approved administration, is the subject of controversial discussions. the...

Full description

Saved in:
Bibliographic Details
Main Authors: Ditsch, Nina (Author) , Kümper, C. (Author) , Summerer-Moustaki, M. (Author) , Rückert, S. (Author) , Toth, Bettina (Author) , Lenhard, M. (Author) , Strauss, M. A. (Author)
Format: Article (Journal)
Language:English
Published: 16 July 2011
In: European journal of medical research
Year: 2011, Volume: 16, Pages: 1-6
ISSN:2047-783X
DOI:10.1186/2047-783X-16-1-7
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/2047-783X-16-1-7
Verlag, lizenzpflichtig, Volltext: https://eurjmedres.biomedcentral.com/articles/10.1186/2047-783X-16-1-7
Get full text
Author Notes:N. Ditsch, C. Kümper, M. Summerer-Moustaki, S. Rückert, B. Toth, M. Lenhard, M.A. Strauss
Description
Summary:The off-label use, referring to the applicability of pharmaceutical drugs beyond the submitted and from the Federal Institute for Drugs and Medical Devices (BfArM, Bundesamt für Arzneimittel und Medizinprodukte) certified and approved administration, is the subject of controversial discussions. the application can be considered in case of severe illness - if no therapeutic alternatives are available - or it exists as a founded perspective for achieving therapeutic success.
Item Description:Gesehen am 13.06.2022
Physical Description:Online Resource
ISSN:2047-783X
DOI:10.1186/2047-783X-16-1-7

Similar Items